A captação de maltose em bactérias é feita por um sistema transportador do tipo ABC composto por uma proteína ligadora de substrato (MalE), duas proteínas transmembrana e uma ATPase. No presente trabalho descrevemos a clonagem, expressão e análise bioquímica e estrutural da proteína MalE da bactéria fitopatogênica Xanthomonas axonopodis pv citri (Xac) O gene malE de Xac foi clonado em vetor de expressão pET28a, a proteína recombinante foi expressa em Escherichia coli e purificada por cromatografia de afinidade ao níquel. Amostras da proteína solúvel foram analisadas quanto à estrutura secundária, interação com possíveis ligantes, estabilidade frente a diferentes condições físico-químicas. Ensaios de cristalização possibilitaram a obtenção de cristais em diferentes condições, um deles apresentou grupo espacial P6122, mas não foi possível resolver a estrutura. Com base nas estruturas conhecidas de ortólogos de MalE, geramos um modelo estrutural para a proteína de Xac e foram feitas análises quanto à interação com trealose e maltose. Modelos estruturais dos componentes transmembrana (LacF e LacG) e ATPase (UgpC) do sistema transportador de maltose de Xac também foram gerados. Os resultados representam uma contribuição importante para o conhecimento sobre a fisiologia e sistemas de transporte de Xac. / Maltose uptake in bacteria is mediated by an ABC transporter comprising a substrate binding protein (MalE), two transmembrane proteins, and one ATPase. In the present study, we describe the cloning, expression and biochemical as well as structural analyses of the MalE protein of the phytopagen Xanthomonas axonopodis pv citri (Xac). The malE gene of Xac was cloned in the pET28a expression vector, the recombinant protein was expressed in Escherichia coli and, subsequently, purified by nickel affinity chromatography. Samples of soluble protein were analyzed regarding secondary structure, interaction with putative ligants and stability under different physico-chemical conditions. Crystallization trials were carried out under different conditions, one particular condition yielded crystal with a P6122space group, but the structure was not solved. Based on known ortholog structures, a structural model for Xac MalE was obtained allowing interaction with modeled threhalose and maltose. Structural models the transmembrane (LacF and LacG) and ATPase (UgpC) components were also obtained. The present results represent an important contribution to the knowledge of the physiology and transporter systems found in Xac.

Molibdênio é um elemento traço envolvido na fixação de nitrogênio, enxofre e carbono. Oligopeptídeos estão envolvidos na nutrição bacteriana e diversos outros processos de sinalização intercelular. O objetivo do presente estudo foi investigar o papel funcional das proteínas ligadoras dos sistemas de captação de molibdato (ModA) e oligopeptídeo (OppA) em Xanthomonas axonopodis pv. citri em condições in vitro e in vivo. O mutante ModA mostrou uma produção diminuída de goma xantana, alteração do biofilme e adesão prejudicada em condições in vitro. In vivo a interação do mutante modA mostrou alterações nas lesões causadas em folhas de grapefruit possivelmente resultado da baixa expressão do gene gumB. O mutante na proteína OppA apresentou células mais co-agregadas alterando a estrutura do biofilme e consequentemente diminuindo sua capacidade de adesão. In vivo, a linhagem mutante não alterou o fenótipo de patogenicidade, mas a sua capacidade de crescimento foi afetada no início da fase estacionária sugerindo que o sistema Opp desempenha um papel nutricional. / Molybdenum is a trace element involved in nitrogen fixation, sulfur and carbon. Oligopeptides are involved in bacterial nutrition and several other intercellular signaling processes. The aim of this study was to investigate the functional role of binding proteins of molybdate (ModA) and oligopeptide (OppA) uptake systems of Xanthomonas campestris pv. citri in in vitro and in vivo conditions. ModA mutant showed a decreased production of xanthan gum, altered biofilm and adhesion impaired in vitro conditions. In vivo ModA mutant interaction showed changes in injuries on leaves of grapefruit possibly due to low expression of the gumB gene. The OppA mutant showed more cells co-aggregated by changing the structure of the biofilm and consequently reducing their capacity to adhere. In vivo, the mutant strain did not modify the phenotype of pathogenicity, but its ability for growth was affected at the early stationary phase suggesting that the Opp system plays a nutritional role.

INTRODUÇÃO: A desregulação da via de sinalização JAK-STAT é uma característica marcante das neoplasias mieloproliferativas (NMPs), doenças clonais da célula tronco hematopoética, dentre as quais encontra-se a mielofibrose (MF). Diversos inibidores de JAK foram desenvolvidos para o tratamento da MF e encontram-se em diferentes fases de desenvolvimento clínico. Devido ao seu desenvolvimento recente, pouco se sabe a respeito do papel de transportadores de membrana na farmacocinética desses compostos. Essas proteínas realizam o influxo e efluxo celular de substratos endógenos e xenobióticos, e alterações na expressão desses transportadores podem influenciar a resposta a esses fármacos. OBJETIVO: Avaliar o efeito de um inibidor comercial da via JAK-STAT na expressão gênica dos transportadores de membrana ABCB1, ABCG2, SLC22A1 e SLCO1A2 em células HepG2, Caco-2 e HEL92.1.7. MÉTODOS: Linhagens de carcinoma hepatocelular (HepG2), adenocarcinoma colorretal (Caco-2) e eritroleucemia humana homozigotas para JAK2V617F (HEL92.1.7) foram cultivadas e tratadas o inibidor comercial da via JAK-STAT JAK Inhibitor I. Para determinar a concentração ideal para o tratamento com o inibidor, as células foram tratadas com diversas concentrações do inibidor de JAK por 24 horas e foram feitos testes de viabilidade celular e fragmentação do DNA. Com as condições de tratamento padronizadas, foi extraído o RNA total das células e sintetizado o cDNA, para análise das expressões de RNAm dos genes ABCB1, ABCG2, SLC22A1 e SLCO1A2 por PCR em tempo real. Foi também avaliada a expressão dos transportadores de efluxo ABCB1 e ABCG2 por citometria de fluxo, utilizando anticorpos primários direcionados a essas proteínas. RESULTADOS: Nas células HepG2, foi observado um aumento da expressão de RNAm de ABCB1 nas células tratadas com 4,00 µM do inibidor de JAK, quando comparado com o controle (células incubadas apenas com o veículo) (P=0,041). Não foi observada alteração da expressão de RNAm de ABCG2 e SLC22A1 com o tratamento com o inibidor de JAK nessa linhagem (P>0,05); a expressão de RNAm de SLCO1A2 não foi detectada nessa linhagem. Nas células Caco-2, a expressão de ABCB1, ABCG2, SLC22A1 e SLCO1A2 não se alterou com o tratamento com o inibidor de JAK nas concentrações utilizadas (0,25 µM a 1,00 µM) por 24 horas (P>0,05). Para as células HEL92.1.7, não foi observada diferença na expressão de RNAm de ABCB1, ABCG2 e SLC22A1 com o tratamento com 1,00 µM do inibidor de JAK por 24 horas em comparação ao controle (P>0,05); nessa linhagem, a expressão de RNAm de SLCO1A2 não foi detectada. A expressão proteica dos transportadores ABCB1 e ABCG2 não sofreu alteração com o tratamento com o inibidor de JAK nas condições utilizadas nas três linhagens celulares estudadas (P>0,05). CONCLUSÕES: Apenas as células HepG2 apresentaram um aumento da expressão de RNAm do transportador de efluxo ABCB1 em concentrações elevadas do inibidor de JAK, sugerindo que os inibidores de JAK podem modular a expressão do gene desse transportador no fígado. O tratamento com o inibidor da via JAK-STAT não foi associado com alterações na expressão proteica de ABCB1 e ABCG2 em todas as células estudadas. / BACKGROUND: JAK-STAT pathway signaling disregulation is a hallmark of myeloproliferative neoplasms (MPN), hematopoietic stem cell clonal diseases, among which is myelofibrosis (MF). Several JAK inhibitors have been developed for MF treatment and are found in different stages of clinical development. Because the recent development of these compounds, the role of drug transporters in their pharmacokinetics is poorly understood. These proteins perform celular influx and effux of endogenous substrates and xenobiotics, and changes in the expression of these drugs transporters may affect the response to these drugs. AIM: To evaluate the effect of a JAK-STAT pathway commercial inhibitor in gene expression of drug transporters ABCB1, ABCG2, SLC22A1 and SLCO1A2 in HepG2, Caco-2 and HEL92.1.7 cells. METHODS: Hepatocellular carcinoma cell line HepG2, colorectal adenocarcinoma cell line Caco-2 and human erythroleukemia homozygous JAK2V617F cell line HEL92.1.7 were grown and treated with the JAK-STAT pathway inhibitor JAK Inhibitor I. In order to determine the optimal concentration for treatment with the inhibitor, cells were treated with several concentrations of JAK inhibitor by 24 hours, and cell viability and DNA fragmentation tests were performed. Once the treatment conditions were standardized, total RNA were obtained from the cells, and cDNA was synthesized in order to evaluate the mRNA expression of ABCB1, ABCG2, SLC22A1 and SLCO1A2 genes, performed by real time PCR. We also evaluate the expression of drug efflux transporters ABCB1 and ABCG2 by flow cytometry, using primary antibodies directed to these proteins. RESULTS: In HepG2 cells, it was observed an increase in ABCB1 mRNA expression in cells treated with 4,00 µM of JAK inhibitor, when compared with controls (cells exposed only to the vehicle) (P=0.041). There was no change in ABCB2 and SLC22A1 mRNA expression with the treatment with JAK inhibitor in this cell line (P>0.05); SLCO1A2 mRNA was not detected in this cell line. In Caco-2 cells, ABCB1, ABCG2, SLC22A1 and SLCO1A2 mRNA expression did not change with treatment with the JAK inhibitor at the concentrations used (0.25 µM to 1.00 µM) by 24 hours (P>0.05). In HEL92.1.7 cells, it was not observed differences in ABCB1, ABCG2 and SLC22A1 mRNA expression with the treatment with 1 µM of JAK inhibitor by 24 hours when compared with controls (P>0.05); in this cell line, SLCO1A2 mRNA was not detected. Protein expression of ABCB1 and ABCG2 drug transporters has not changed with treatment with the JAK inhibitor under the conditions used in the three cell lines studied. CONCLUSIONS: Only HepG2 cells presented an increase in mRNA expression of drug efflux transporter ABCB1 in presence of high levels of JAK inhibitor, suggesting that JAK inhibitors could modulate this transporter gene expression in liver. Treatment with JAK-STAT pathway inhibitor was not associated with changes in ABCB1 and ABCG2 protein expression in all cell lines studied.

Les sucres, sont des signaux métaboliques, impliqués dans le développement des plantes et leurs réponses aux contraintes du milieu. Les transporteurs de sucres se révèlent à la fois acteurs de la répartition des sucres et cibles de leur signalisation. L'ASR (ABA, Stress and Ripening) de la Vigne, VvMSA, étant identifiée comme protéine régulatrice de l'expression génique du transporteur d’hexoses VvHT1, l'objectif de la thèse est d'appréhender ses rôles physiologiques dans une démarche de biologie intégrée.Le premier axe a été dédié à la mise en place des modèles biologiques, des cellules embryogènes et non embryogènes de Vigne, issues du même fond génétique mais cultivées sur deux sources de carbone différentes. La caractérisation des cinétiques de prolifération et l'analyse des métabolomes ont mis en évidence leur sensibilité/tolérance différentielle à la carence en sucres. Le deuxième axe a porté sur la régulation de VvHT1 dans les deux types cellulaires sauvages et leurs mutants de surexpression/répression de VvMSA. L'approche pharmacologique utilisant des analogues du glucose, l'analyse de l'expression génique, le transport du glucose et l'activité des enzymes de la glycolyse indiquent que VvMSA affecte l'expression de VvHT1 par la voie dépendante du métabolisme du glucose. Le troisième volet a été réalisé par une approche de protéomique quantitative et comparative des protéines nucléaires des cellules embryogènes sauvages et réprimées pour VvMSA. Les protéines à expression significativement affectée par l'absence de l'ASR, laissent entrevoir un nouveau rôle à l'interconnexion des réponses métaboliques aux stress et la régulation épigénétique de l'expression génique. / Sugars are metabolic signals involved in plant development and responses to environmental cues. Sugar transporters are both actors of sugar partitioning and targets of sugar signaling. As Grape ASR (ABA, Stress, Ripening), VvMSA, is identified as a regulatory protein controlling gene expression of the hexose transporter VvHT1, the aim of the PhD thesis is to assess its physiological functions by an integrative biology approach. The first part of the study consisted in the establishment of biological models, embryogenic and non embryogenic grape cells, sharing the same genetic background but growing on distinct carbon sources. The characterization of the proliferation kinetics and metabolomes of both cell types revealed differences in their sensitivity/tolerance to sugar starvation.The second objective was focused on VvHT1 expression regulation in both cell types and their mutants overexpressing or silenced for VvMSA. The pharmacological approach using glucose analogues, coupled to the analysis of gene expression, glucose transport and glycolytic enzymes activity, suggest that VvMSA affects VvHT1 expression through a glucose metabolism dependent pathway.The third research axis was carried out through a quantitative and comparative proteomic analysis of nuclear proteins in embryogenic wild type and VvMSA silenced cells. Proteins whose expression is affected by ASR repression suggest a new functional role of VvMSA at the interplay between metabolic responses to stress and epigenetic regulation of gene expression.

Au cours des interactions plante/agent pathogène, la disponibilité en sucres est un des enjeux majeurs pour les deux partenaires. Il s'établit donc une compétition vis-à-vis des ressources carbonées entre l'agent pathogène hétérotrophe pour le carbone et la plante consommant de l'énergie pour se défendre. Les transporteurs de sucres sont les acteurs moléculaires qui interviennent dans cette compétition et probablement dans le devenir de l'interaction. L'objectif de cette étude est de déterminer l'implication des transporteurs de sucres au cours de l'interaction entre la plante modèle Arabidopsis thaliana et le champignon nécrotrophe Botrytis cinerea.Parmi la famille des transporteurs d'hexoses (STPs) d'A. thaliana, l'expression du gène STP13 est régulée positivement durant l'infection par B. cinerea. Le rôle potentiel de STP13 au cours de cette interaction a donc été étudié à l'aide de plantes transgéniques (Knock-Out et surexpresseur). Le suivi du développement des symptômes et la mesure d'absorption du glucose ont permis de montrer des modifications phénotypiques entre les différents génotypes étudiés. Les résultats indiquent une corrélation entre le niveau d'expression de STP13, le transport de glucose et le développement du champignon, confortant ainsi le rôle de STP13 dans la tolérance face à B. cinerea.Les résultats préliminaires de l'étude du transport de glucose à l'échelle cellulaire montrent une inhibition dans des conditions mimant l'infection. Ces analyses ont été effectuées grâce à un modèle constitué d'une suspension cellulaire d'A. thaliana subissant un traitement éliciteur à partir d'un extrait protéique de B. cinerea.Nous nous sommes également intéressés au transport de saccharose à l'échelle de la plante infectée. Nos résultats suggèrent que l'inoculation par le champignon modifie les flux de saccharose classiquement observés créant ainsi une nouvelle force d'appel. Ainsi, la feuille infectée se comporte comme un nouveau puits. Ces travaux de recherche s'inscrivent dans la nécessité d'une meilleure compréhension des mécanismes de transport des sucres qui permettra à terme d'agir sur les capacités de résistance des plantes vis-à-vis d'agents pathogènes. / During plant/pathogen interactions, sugar availability is one of the major issues for both partners. There is a competition for the same carbohydrates necessary for carbon supply on the pathogen's side and to support the additional energy demand for plant's defense. Sugar transporters are the molecular actors in this competition which is determinant for the final outcome of the interaction. In this study, we characterized the implication of sugar transporters in the interaction between the model plant Arabidopsis thaliana and the necrotrophic fungus Botrytis cinerea.Among the A. thaliana hexose transporter family (STPs), STP13 is induced during B. cinerea infection. A potential role of STP13 in this interaction was investigated using transgenic plants (Knock-Out and over-expressor lines). Disease symptoms characterization and glucose uptake assays showed phenotypical variations between the different genotypes. It seems that STP13 expression, glucose uptake and fungus spreading are correlated pointing to a role of STP13 in tolerance to B. cinerea. Other preliminary results showed an inhibition of the cellular glucose uptake upon condition mimicking B. cinerea infection. These analyses were performed on a model composed of an A. thaliana cell suspension elicited with a proteinaceous extract from B. cinerea.We also studied sucrose fluxes in the whole infected plant. Our results suggest that fungus inoculation modifies the usual fluxes creating a new sink.This study may lead to a better understanding of sugar transport mechanisms to improve plant resistance capacity against pathogens in the future.

Plasma membrane transport proteins play a crucial role in all cells by conferring to the cell surface a selective permeability to a wide range of ions and small molecules. The activity of these transporters is often regulated by controlling their amount at the plasma membrane, via intracellular trafficking. The recent boom in the numbers of crystallized transporters shows that many of them that belong to different functional families with little sequence similarity adopt the same structural fold implying a conserved transport mechanism. These proteins belong to the APC (Amino acid-Polyamine-organoCation) superfamily and their fold is typified by the bacterial leucine transporter LeuT. This LeuT fold is characterized by inverted structural repeats of 5 transmembrane domains that harbor the central substrate-binding site and a pseudo-symmetry axis parallel to the membrane. The yeast Saccharomyces cerevisiae possesses about 16 amino acid permeases (yAAPs) that belong to the APC superfamily and that display various substrate specificity ranges and affinities. Topological, mutational analysis and in silico data indicate that yAAPS adopt the LeuT fold.<p><p>In this work we combined computational modeling and yeast genetics to study substrate binding by yAAPs and the endocytosis of these transporters in response to substrate transport. In the first part of this work, we analyzed the selective recognition of arginine by the yeast specific arginine permease, Can1. We constructed three-dimensional models of Can1 using as a template the recently resolved structure of AdiC, the bacterial arginine:agmatine antiporter, which is also a member of the APC superfamily. By comparison of the binding pockets of Can1 and Lyp1, the yeast specific lysine permease, we identified key residues that are involved in the recognition of the main and side chains of arginine. We first showed that the network of interactions of arginine in Can1 is similar to that of AdiC, and that the selective recognition of arginine is mediated by two residues: Asn 176 and Thr 456. Substituting these residues by their corresponding residues in Lyp1 converted Can1 into a specific lysine permease. In the second part of this work, we studied the regulation of two permeases, Can1 and the yeast general amino acid permease, Gap1. In the presence of their substrates, Gap1 and Can1 undergo ubiquitin-dependent endocytosis and targeting to the vacuolar lumen for degradation. We showed that this downregulation is not due to intracellular accumulation of the transported amino acids but to transport catalysis itself. By permease structural modeling, mutagenesis, and kinetic parameter analysis, we showed that Gap1 and Can1 need to switch to an intermediary conformational state and persist a minimal time in this state after binding the substrate to trigger their endocytosis. This down-regulation depends on the Rsp5 ubiquitin ligase and involves the recruitment of arrestin-like adaptors, resulting in the ubiquitylation and endocytosis of the permease.<p><p>Our work shows the importance of the structural analysis of yAAPs to get further insight into the different aspects of their function and regulation. We validate the use of a bacterial APC transporter, AdiC, to construct three-dimensional models of yAAPs that can be used to guide experimental analyses and to provide a molecular framework for data interpretation. Our results contribute to a better understating of the recognition mode of amino acids by their permeases, and the regulation of this transport in response to substrate binding. / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

La sénescence endothéliale est une étape précoce menant à la dysfonction endothéliale, laquelle favorise la pathogénèse de maladies cardiovasculaires lors du vieillissement physiologique et, de manière prématurée, chez le sujet diabétique. La première étude indique que le stress oxydant favorise l’induction du système angiotensine local menant à la sénescence et la dysfonction endothéliale dans les cellules endothéliales en culture. La deuxième étude indique que l’expression redox-sensible des co-transporteurs sodium-glucose 2 (SGLT2) entraîne via le système angiotensine la sénescence et la dysfonction endothéliale en réponse au high glucose. De plus, les observations indiquent que l’Empagliflozine, un inhibiteur sélectif de SGLT2, et les anthocyanes du jus de cassis sont capables d’inhiber l’induction de la sénescence endothéliale au glucose. De ce fait, le système angiotensine local et le SGLT2 sont des cibles intéressantes pour retarder le vieillissement vasculaire. / Endothelial senescence is an early step to endothelial dysfunction, known to favor the development of cardiovascular diseases during ageing, or its accelerated form in diabetes. The first in vitro study shows that the activation of the local angiotensin system is favored by the oxidative stress and leads to endothelial senescence and dysfunction. The second study indicates that endothelial senescence and dysfunction in response to high glucose are driven by the redox-sensitive expression of sodium-glucose co-transporters SGLT-2, via the angiotensin system. Moreover, data also indicate that empagliflozin, a SGLT2 selective inhibitor, and anthocyans from black-currant juice can inhibit the glucose-induced endothelial senescence. Therefore, the local angiotensin system and SGLT2 are promising targets to stunt vascular ageing.

Les cellules dendritiques (DCs) sont des cellules spécialisées dans la présentation de l'antigène aux lymphocytes (CPAs), capables d'initier des réponses immunitaires adaptatives et ce sont également les acteurs majeurs de la présentation croisée des antigènes exogènes par le complexe majeur d’histocompatibilité de classe I (CMH-I). Les mécanismes moléculaires et cellulaires de la présentation croisée ont beaucoup été étudiés, mais des questions importantes restent à élucider. Notre laboratoire a précédemment montré que la pré-incubation à basse température des DCs déficientes pour TAP (transporter associated with antigen processing) normalise l’expression de molécules du CMH-I à la surface et la présentation croisée des antigènes phagocytés par une voie dépendante du protéasome, suggérant que les phagosomes pourraient être dotés d’un transporteur alternatif pour importer les peptides générés dans le cytosol par le protéasome. Comme la source de CMH-I chargés par cette voie reste incertaine, il est possible que le rôle de TAP dans la présentation croisée des antigènes phagocytés soit indirect et limité à fournir les molécules de CMH-I disponibles pour un chargement pendant leur recyclage. Ainsi, notre objectif était de déterminer le rôle exact de TAP dans le transport de peptides à l'intérieur du phagosome et d'évaluer le rôle de TAP-L (TAP-like), un transporteur lysosomal ATP-dépendant avec une fonction putative dans la présentation antigénique. Nous avons mis au point une technique de transport des peptides par cytométrie en flux (phagoFACS) et montré que TAP est présent dans les phagosomes des DCs et est capable de transporter des peptides ayant une forte affinité pour TAP d'une manière ATP-dépendante. Cette technique permet l'exclusion des phagosomes ayant un défaut d’intégrité membranaire, obtenus lors de la préparation des phagosomes, et apporte une preuve directe de l'accumulation du peptide à l'intérieur des phagosomes. Les paramètres affectant cette accumulation sont la maturation phagosomale et la présence de molécules CMH-I liant le peptide. De façon surprenante, en l'absence de TAP, le peptide SIINFEKL dérivé de l’ovalbumine ayant une affinité intermédiaire pour TAP est transporté de manière ATP-dépendante dans le phagosome. Ceci est cohérent avec l’hypothèse suggérant la présence d'un autre transporteur de peptide dans les phagosomes des DCs. Nous avons utilisé la même technique pour évaluer la fonction physiologique de TAP-L dans le transport de peptides et montré que TAP-L est présent dans les phagosomes et serait responsable de l’import de peptides dans ces vésicules. Nos résultats suggèrent aussi que TAP-L semble jouer un rôle dans la présentation croisée des antigènes phagocytés à basse température. Ceci a été observé dans des DCs déficientes pour TAP et TAP-L, indiquant que les deux transporteurs pourraient coopérer pour assurer l’import des peptides dans les phagosomes. Nous avons également pu démontrer un rôle de TAP-L dans la présentation de l’antigène par CMH-II. Ces résultats nous encouragent à explorer les mécanismes sous-jacents à ces fonctions pour comprendre la contribution relative de chaque transporteur de peptides dans la présentation antigénique. / Dendritic cells (DCs) are potent antigen-presenting cells, capable of activating resting T cells and of initiating primary and stimulating memory immune responses. DCs can efficiently use internalized antigens for presentation by major histocompatibility class I (MHC-I) molecules: a phenomenon referred to as “cross-presentation.” Cross-presentation is important in priming of CD8+ T-cell responses to a variety of pathogens and to tumors as well as in immune tolerance to self and in autoimmunity. The molecular and cell biological mechanisms underlying cross-presentation have been studied intensively but important issues remain unclear. Our laboratory has previously shown that the pre-incubation of TAP-deficient DCs at low temperature normalized surface MHC-I expression and cross-presentation of phagocytosed antigens in a proteasome-dependent pathway. This suggested that phagosomes might harbor an alternative peptide transporter to import peptides generated by cytosolic proteasome complexes. As the source of MHC-I loaded in this pathway remains unclear, it is possible that the principal or partial role of TAP in proteasome-dependent cross-presentation of phagocytosed antigens is to provide recycling cell surface class I molecules. Our aim was to assess the exact role of TAP in peptide transport into phagosomes and to examine the role of the transporter associated with antigen processing-like (TAP-L), a lysosomal transporter with a putative function in antigen presentation. We have developed an assay of peptide transport using flow cytometry (phagoFACS) and shown that TAP is present in DC phagosomes and capable of transporting at least peptides with high affinity to TAP in an ATP-dependant manner. Using this assay, which allowed for eliminating background due to leaky vesicles, we were able to provide direct evidence of peptide accumulation inside phagosomes. ATP-dependant peptide accumulation inside phagosomes was affected by phagosomal maturation and by the presence of a peptide-binding MHC class I-molecule. Surprisingly, in the absence of TAP, another peptide transporter may be able to transport a peptide with intermediate affinity to TAP, namely the ovalbumin peptide SIINFEKL, in an ATP-dependant manner. We used the same technique to assess the function of TAP-L in peptide transport and found that TAP-L may be involved in peptide import into phagosomes. Additional results suggest that TAP-L plays a role in MHC-II presentation and cross-presentation of phagocytosed antigens at low temperature. The latter was shown in DCs lacking both transporters, suggesting that TAP and TAP-L might cooperate to ensure peptide import into phagosomes. The mechanisms underlying these functions should be explored to understand the relative contribution of each peptide transporter to antigen presentation.

Les membranes cellulaires jouent un rôle important dans l’absorption des médicaments et la distribution de ceux-ci dans le corps humain. Elles contiennent différents transporteurs membranaires qui sont responsables des profils pharmacocinétiques, d’innocuité et d’efficacité des xénobiotiques. Lors du développement d’un médicament, il s’avère donc indispensable, de prédire l’interaction des nouveaux composés avec les transporteurs présents dans l’organisme. Le but du projet de recherche est de créer un nouvel outil pour étudier le comportement de la glycoprotéine-P (P-gp), un transporteur membranaire responsable du rejet de nombreux composés, sur différents médicaments. Pour cela, un modèle non cellulaire est développé en utilisant des protéoliposomes : des liposomes dans lesquels des transporteurs sont incorporés. La méthodologie consiste tout d’abord à produire, extraire et purifier la protéine d’intérêt à partir de deux systèmes d’expression : MDCK-MDR1 (cellules de chien transfectées avec le gène humain MDR1) et Pichia pastoris (levures) fin de déterminer les avantages et les limites de ces deux types cellulaires. Différentes méthodes de reconstitution dans des protéoliposomes ont ensuite été testées avec la P-gp obtenue. Puis, l’activité ATPasique de la P-gp reconstituée a été évaluée en présence de différents substrats. Les protocoles de culture cellulaire, d’extraction et de purification des deux systèmes d’expression ont été implémentés avec succès au sein du laboratoire. Les résultats montrent que les rendements obtenus sont supérieurs avec les levures qu’avec les cellules de mammifère. En outre, Pichia pastoris offre les avantages d’être facile et rapide à cultiver et peu couteux. Les premiers résultats d’activité ATPasique obtenus avec la P-gp reconstituée en protéoliposomes étaient prometteurs mais n’ont pas été reproduits en raison de la dégradation de la protéine membranaire. Les prochaines études du projet porteront sur un autre transporteur membranaire de la famille ABC, BCRP, une protéine de plus petite taille qui devrait montrer une plus grande stabilité pour mener à bien les tests. / Cellular membranes play an important role in the absorption and distribution of drugs in the human body. They contain different membrane transporters, which are responsible for the pharmacokinetic properties of drugs, as well as the safety and efficiency of their diffusion. When developing a new drug, it is thus of utmost importance to study the way that it will interact with the transporters present within the body. The aim of this study was to evaluate a new tool for measuring permeability in order to understand the function and mecanisms of P-glycoprotein (P-gp). P-gp is a transporter that is responsible for the rejection of many different compounds found in various drugs. This study thus seeks to use proteoliposomes to develop non-cellular models of membrane permeability including efflux and uptake transporters. This novel model of permeability will be utilized to study the underlying mechanisms of membrane permeability to xenobiotics. The human P-gp was produced, extracted and purified using two different expression systems: MDCK-MDR1 cells (Madin-Darby canine kidney cells transfected with the human MDR1 gene) and Pichia pastoris. Both expression systems were studied in order to compare the strengths and weaknesses of each system. We then tested different methods of reconstituting the P-gp into protéoliposomes. Finally, we measured the level of ATPase activity using different substrates. The protocols of cell culture, extraction and purification of both expression systems were accomplished in a laboratory during this study. These results demonstrated that expressing P-gp using yeast was more effective than that of mammalian cells. Furthermore, working with Pichia pastoris offers multiple advantages: expressing P-gp was easier, faster and cheaper than working with mammalian cells. The first measurements of ATPase activity using reconstituted P-gp proteoliposomes were promising, however they proved difficult to reproduce due to the possible degradation of the membrane protein.Further studies in this project will look to evaluate another ABC membrane transporter, BCRP. This smaller protein should prove to be more stable than P-gp, facilitating experimentation.

En milieu forestier, la décomposition de la matière organique d’origine végétale et son assimilation par les microorganismes sont des processus essentiels au bon fonctionnement des sols et du cycle du carbone. Les mécanismes impliqués dans ces phénomènes de dégradation sont fortement contrôlés par les champignons saprotrophes qui sécrètent de nombreuses enzymes hydrolytiques afin d’accéder à leur principale source de nutriments qui se trouve sous la forme de polysaccharides (cellulose et hémicelluloses). L’hydrolyse enzymatique de ces polymères végétaux engendre une grande diversité de composés de faible poids moléculaire (mono- et oligosaccharides). Ces molécules pénètrent dans la cellule fongique via des systèmes de transporteurs membranaires dont la présence/absence et la spécificité de substrat contribuent à la versatilité métabolique de ces microorganismes du sol. La nature de l’essence forestière affecte fortement la diversité et la composition des communautés fongiques. Dans ce contexte, nous avons émis l’hypothèse que les communautés fongiques sélectionnées par les différentes essences forestières diffèrent entre elles par la diversité des mécanismes qu’elles mettent en place lors du processus de décomposition de la matière organique d'origine végétale et lors du transport des produits de dégradation ; et que de ce fait chaque communauté fongique est spécifiquement adaptée à la nature de la litière produite par l’espèce végétale considérée. Par des approches de séquençage haut-débit d’amplicons générés à partir d’ADNc environnementaux, nous avons analysé la diversité des transcrits codant des protéines fongiques impliquées à la fois dans la dégradation des polysaccharides végétaux et dans le transport des sucres issus de cette hydrolyse enzymatique au sein de sols localisés sous des forêts de hêtres et d’épicéas. L’analyse des données obtenues a mis en évidence des transcrits jusqu’alors inconnus et spécifiquement retrouvés pour plus 80% d’entre eux sous l’un des deux couverts végétaux conduisant ainsi à un effet significatif de l’essence forestière sur la composition des gènes exprimés par les communautés fongiques. Des transporteurs potentiellement spécifiques du mannose ont été détectés, pour la première fois, sous la forêt d’épicéas par une approche de crible fonctionnel dans la levure de banques d’ADNc environnementaux. Or, cette essence forestière est connue pour posséder d’importantes quantités de mannose au niveau de ses hémicelluloses. Les résultats obtenus au cours de cette thèse soulignent l’importance d’étudier la diversité fonctionnelle des communautés fongiques pour comprendre l’impact du couvert végétal sur leur composition et le fonctionnement des écosystèmes forestiers / The degradation of plant biomass is an essential process for the proper functioning of forest soils and terrestrial carbon cycling. Mechanisms involved in these processes are strongly controlled by saprotrophic fungi which secrete several hydrolytic enzymes to access at their primary nutrient sources found under the form of polysaccharides (cellulose and hemicelluloses). Enzymatic hydrolysis of plant polymers releases a high diversity of low molecular weight compounds (mono- and oligosaccharides). These molecules enter in fungal cell using transmembrane transporter systems. Consequently, the presence/absence and the substrate specificity of these transporters might contribute to the metabolic versatility of soil fungi. Several studies have demonstrated that tree species strongly affect diversity and composition of fungal communities. In this context, we hypothesized that the fungal communities selected by the different tree species expressed specific lignocellulolytic enzymes and sugar transporters; and thereby each fungal community was specifically adapted to the nature of litter produced by the tree species considered. We assessed, by the high-throughput sequencing of gene-fragments amplified from soil cDNA, the impact of tree species (Beech vs Spruce) on the diversity of genes encoding either lignocellulolytic enzymes or sugar porters expressed by soil fungi in two mono-specific forests. Our results revealed that most detected genes, encoding either lignocellulolytic enzymes or sugar transporters, have an unknown origin and are specifically found (for more than 80% of them) in one of the two forest soils. This work showed a significant “tree species effect” on the composition of functional genes expressed by soil fungi and suggests that beyond the species level, functional diversity of fungal communities must be addressed to better understand ecosystem functioning. Moreover, by using a functional metatranscriptomic approach, we identified functional transporter sequences differing with respect to their substrate specificities. From a spruce cDNA library, and for the first time, we identified high affinity or mannose specific transporters. Coincidently, as opposed to beech, spruce is indeed a tree species with a large proportion of mannose in its hemicelluloses